Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
ORMP
Oramed Pharmaceuticals Inc.
Oramed's POD platform constitutes the core drug-delivery technology enabling oral administration of therapeutic proteins (e.g., oral insulin).
|
$116.86M |
$2.87
-0.52%
|
|
RANI
Rani Therapeutics Holdings, Inc.
RaniPill is the core drug-delivery platform enabling oral administration of biologics, central to the company's offering.
|
$116.43M |
$1.64
+1.86%
|
|
LPTX
Leap Therapeutics, Inc.
Leap Therapeutics is a biotech company focused on oncology therapies, with lead assets in antibody-based cancer treatments.
|
$116.14M |
$2.04
+367.43%
|
|
LUCD
Lucid Diagnostics Inc.
EsoCheck is a diagnostic collection device used to obtain esophageal cells for testing, aligning with Diagnostic Equipment.
|
$116.07M |
$1.06
-2.75%
|
|
IKT
Inhibikase Therapeutics, Inc.
IKT's lead program IKT-001Pro is an oral small-molecule therapeutic prodrug, fitting the 'Oral Small Molecule Therapeutics' investable theme.
|
$114.76M |
$1.54
-1.59%
|
|
SLGL
Sol-Gel Technologies Ltd.
SGT-610 and SGT-210 target rare dermatologic diseases (Gorlin syndrome, Darier disease), aligning with the Rare Diseases investable theme.
|
$113.35M |
$39.40
-2.45%
|
|
GANX
Gain Therapeutics, Inc.
GT-02287 is a small-molecule therapeutic candidate, aligning with the major product category of oral small-molecule therapeutics.
|
$112.88M |
$3.15
+7.71%
|
|
UNCY
Unicycive Therapeutics, Inc.
Lead programs Oxylanthanum Carbonate (OLC) and UNI-494 are oral small-molecule therapeutics targeting kidney disease and hyperphosphatemia/acute kidney injury.
|
$111.27M |
$6.29
+10.05%
|
|
SEER
Seer, Inc.
SP100 instrument and related proteomics hardware qualify as Diagnostic Equipment.
|
$109.86M |
$1.97
+2.07%
|
|
AVHHL
AVITA Medical, Inc.
AVITA Medical’s core offerings are wound care devices and dermal matrices (RECELL system, RECELL GO, PermeaDerm, Cohealyx) used in wound management, fitting the Wound Care Devices category.
|
$109.32M |
$0.72
|
|
ENTX
Entera Bio Ltd.
Entera Bio's N-Tab platform is a drug-delivery platform enabling oral administration of large-molecule peptides.
|
$108.68M |
$2.48
-0.40%
|
|
COYA
Coya Therapeutics, Inc.
COYA's autologous regulatory T cell therapy program (COYA 101) represents a direct cell therapy product line.
|
$106.71M |
$6.38
+5.28%
|
|
ICAD
iCAD, Inc.
iCAD operates in the Medical Imaging domain, providing imaging software for breast health diagnostics.
|
$105.91M |
$3.87
|
|
HLVX
HilleVax, Inc.
Direct vaccine development activity with norovirus vaccine candidates (HIL-216.00) and existing vaccine focus.
|
$104.79M |
$2.09
|
|
ATRA
Atara Biotherapeutics, Inc.
Atara focuses on tab-cel (Ebvallo), an allogeneic T-cell therapy.
|
$104.36M |
$14.96
+2.68%
|
|
MBOT
Microbot Medical Inc.
LIBERTY functions as a vascular/interventional device for endovascular surgery, aligning with Vascular Intervention Devices.
|
$104.30M |
$2.31
+22.87%
|
|
INO
Inovio Pharmaceuticals, Inc.
INO's core DNA medicines platform and lead candidate INO-3107 are gene therapy products based on DNA plasmids delivered via CELLECTRA; maps to gene therapy.
|
$104.16M |
$1.97
+8.56%
|
|
RCEL
AVITA Medical, Inc.
RECELL System and Cohealyx/PermeaDerm are wound care devices used for wound closure and healing.
|
$104.08M |
$3.90
+3.87%
|
|
ZNTL
Zentalis Pharmaceuticals, Inc.
Zentalis is a biotech company focused on oncology therapies, centered on cancer indications with their lead asset azenosertib.
|
$103.88M |
$1.45
+0.35%
|
|
QIPT
Quipt Home Medical Corp.
Quipt designs/markets medical devices and biometric sensing technology used in home respiratory care and diabetes monitoring (CGMs).
|
$103.85M |
$2.40
+3.45%
|
|
EUDA
EUDA Health Holdings Limited
EUDA's core biotech activity is a stem cell platform and cell therapy development using iPSCs.
|
$102.76M |
$2.88
-0.17%
|
|
STTK
Shattuck Labs, Inc.
SL-325 is a monoclonal antibody targeting DR3, making Monoclonal Antibody Therapeutics a direct product category.
|
$102.03M |
$2.13
+6.22%
|
|
DCGO
DocGo Inc.
DocGo directly provides Home Health & Hospice services, including in-home/mobile healthcare delivery.
|
$101.72M |
$1.03
+1.97%
|
|
CLNN
Clene Inc.
Clene's proprietary clean-surfaced nanotechnology platform operates as a drug delivery platform for CNM-Au8.
|
$101.40M |
$10.12
+7.14%
|
|
CNTX
Context Therapeutics Inc.
The company's pipeline centers on T cell engaging bispecific antibodies (CTIM-76, CT-95, CT-202).
|
$101.37M |
$1.14
+1.79%
|
|
ATOS
Atossa Therapeutics, Inc.
Atossa is a clinical-stage biotech focused on oncology with Z-endoxifen as its lead cancer therapy candidate.
|
$100.73M |
$0.78
+1.61%
|
|
COEP
Coeptis Therapeutics, Inc.
GEAR Cell Therapy Platform is a core cell therapy biotech asset.
|
$98.60M |
$18.84
+6.80%
|
|
ACOG
Alpha Cognition Inc. Common Stock
ZUNVEYL is Alpha Cognition's lead therapeutic targeting Alzheimer's disease.
|
$98.42M |
$6.08
-0.33%
|
|
KBLB
Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories produces recombinant spider silk proteins via transgenic silkworms, a core product category defined as Recombinant Proteins & Enzymes.
|
$97.28M |
$0.09
|
|
PLRX
Pliant Therapeutics, Inc.
Company's lead and mid-stage assets include oral small-molecule therapeutics (bexotegrast and PLN-101095) targeting integrin pathways.
|
$96.99M |
$1.58
+0.64%
|
|
ULBI
Ultralife Corporation
Products targeted at medical use (X5 medical care products, wearable power) place Ultralife in Medical Devices & Biometrics.
|
$96.53M |
$5.83
-0.68%
|
|
ANEB
Anebulo Pharmaceuticals, Inc.
Anebulo's lead candidate selonabant is a small molecule therapeutic (initially oral) targeting cannabis-induced CNS effects; thus aligns with Oral Small Molecule Therapeutics.
|
$96.14M |
$2.41
-3.21%
|
|
ANVS
Annovis Bio, Inc.
Buntanetap is described as an orally administered small molecule therapeutic, aligning with the 'Oral Small Molecule Therapeutics' investable theme.
|
$95.87M |
$4.94
+2.49%
|
Showing page 25 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
